Rule 8.3 - INVERNESS MEDICAL INNOVATIONS INC

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing BARCLAYS PLC (Note 1) Company dealt in INVERNESS MEDICAL INNOVATIONS INC Class of relevant security COM STK USD0.001 to which the dealings being disclosed relate (Note 2) Date of dealing 08 July 2009 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant 2,183,701 2.77% 113,664 0.14% securities (2) Derivatives 0 0.00% (other than options) (3) Options and 170,500 0.22% 71,500 0.09% agreements to purchase/sell Total 2,354,201 2.99% 185,164 0.24% (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of Long Short relevant security: Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of Securities Price per unit (GBP) Purchase 200 30.9705 Purchase 2,000 30.3885 Purchase 1,000 30.506 Purchase 1,000 30.374 Purchase 300 30.38666667 Purchase 4,300 30.40976744 Purchase 200 30.67 Purchase 800 30.44875 Purchase 276 30.69 Purchase 270 30.69 Purchase 430 30.57604651 Purchase 100 30.69 Purchase 200 31.625 Purchase 400 31.72 Purchase 20,000 31.522044 Purchase 200 30.44 Purchase 778 30.6900 USD Purchase 22 30.6900 USD Purchase 56 30.6900 USD Purchase 112 30.6900 USD Purchase 169 30.6900 USD Purchase 555 32.1538 USD Purchase 621 30.6900 USD Purchase 2,657 31.4554554 Purchase 708 30.6900 USD Purchase 200 30.9705 Purchase 1,937 30.69 Purchase 200 30.928 Purchase 900 30.6264 Purchase 7,400 30.978 Purchase 8 30.8175 Purchase 100 30.68 Purchase 621 32.1538 USD Purchase 200 30.978 Purchase 300 31.37333333 Purchase 2,742 31.30983589 Purchase 1,125 31.5 Purchase 600 31.3325 Purchase 800 31.23375 Purchase 1,000 31.405 Purchase 5,000 31.1078 Purchase 200 31.09 Purchase 200 30.67 Purchase 200 30.65 Purchase 200 30.45 Purchase 1,600 30.8025125 Sale 200 30.45 Sale 300 30.89666667 Sale 200 30.9705 Sale 2,657 31.4554554 Sale 743 30.69 Sale 1,194 30.69 Sale 708 30.6900 USD Sale 600 31.29666667 Sale 32 30.6900 USD Sale 250 31.0453 USD Sale 100 30.6900 USD Sale 200 30.67 Sale 79 30.75 Sale 200 30.928 Sale 621 30.6900 USD Sale 212 30.6900 USD Sale 1,000 30.506 Sale 381 31.0453 USD Sale 32 31.0453 USD Sale 200 30.978 Sale 400 31.72 Sale 1,800 31.53611111 Sale 400 30.66 Sale 8,300 31.52481928 Sale 500 31.496 Sale 100 30.87 Sale 100 30.76 Sale 200 31.09 Sale 8,312 31.52716073 Sale 200 31.09 Sale 8,300 30.9398747 Sale 16 30.6900 USD Sale 40 30.76 Sale 200 30.928 Sale 7,400 30.978 Sale 925 31.5 Sale 2,742 31.30983589 Sale 276 30.69 Sale 8 30.8175 Sale 466 31.40399142 Sale 100 31.5 Sale 900 30.6264 Sale 100 31.5 Sale 422 31.67265403 (b) Derivatives transactions (other than options) Product name, Long/Short Number of Price per (e.g. CFD) (Note 6) Securities unit (GBP) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, Number of Exercise Type, e.g. Expiry Option money e.g. call selling, securities to price American, date paid/received option purchasing, which the option European etc. per unit (GBP) varying etc. relates (GBP) (ii) Exercising Product name, e.g. Number of Exercise price per call option securities unit (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION None Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. Is a Supplemental Form 8 attached? (Note 9) YES Date of disclosure 09 July 2009 Contact name Geoff Smith Telephone number 020 7116 2913 If a connected EFM, name of offeree/offeror with which connected If a connected EFM, state nature of connection (Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk SUPPLEMENTAL FORM 8 DETAILS OF OPEN POSITIONS (This form should be attached to Form 8.1, Form 8.1(b)(ii) or Form 8.3, as appropriate) OPEN POSITIONS (Note 1) Product name, Written or Number of securities Exercise price Type, e.g. Expiry date e.g. call option purchased to which the option (Note 2) American, or derivative relates European etc. Option Purchased -700 40.0000 AMER 16/01/2010 Option Purchased 100 15.0000 AMER 16/01/2010 Option Purchased 100 12.5000 AMER 22/01/2011 Option Purchased -100 25.0000 AMER 21/11/2009 Option Purchased -100 22.5000 AMER 22/01/2011 Option Purchased -100 17.5000 AMER 16/01/2010 Option Purchased -100 17.5000 AMER 22/08/2009 Option Purchased -200 35.0000 AMER 21/11/2009 Option Purchased -200 25.0000 AMER 20/02/2010 Option Purchased -400 35.0000 AMER 22/01/2011 Option Purchased -23,600 25.0000 AMER 22/08/2009 Option Purchased -500 20.0000 AMER 22/08/2009 Option Purchased 200 15.0000 AMER 22/01/2011 Option Purchased -1,000 30.0000 AMER 18/07/2009 Option Purchased -1,200 35.0000 AMER 22/08/2009 Option Purchased -1,200 30.0000 AMER 22/01/2011 Option Purchased -1,700 30.0000 AMER 21/11/2009 Option Purchased -2,000 40.0000 AMER 18/07/2009 Option Purchased -2,000 22.5000 AMER 22/08/2009 Option Purchased -2,400 25.0000 AMER 16/01/2010 Option Purchased -4,600 25.0000 AMER 16/01/2010 Option Purchased -11,100 30.0000 AMER 18/07/2009 Option Purchased -17,800 30.0000 AMER 22/08/2009 Option Purchased -500 20.0000 AMER 22/08/2009 Option Purchased 1,800 40.0000 AMER 22/01/2011 Option Purchased 22,300 25.0000 AMER 22/08/2009 Option Purchased 7,400 35.0000 AMER 22/08/2009 Option Purchased 6,900 30.0000 AMER 16/01/2010 Option Purchased 6,400 30.0000 AMER 16/01/2010 Option Purchased 5,800 40.0000 AMER 22/08/2009 Option Purchased 4,500 35.0000 AMER 18/07/2009 Option Purchased 4,400 35.0000 AMER 16/01/2010 Option Purchased 4,400 20.0000 AMER 16/01/2010 Option Purchased 2,700 45.0000 AMER 21/11/2009 Option Purchased 2,600 50.0000 AMER 16/01/2010 Option Purchased 100 17.5000 AMER 22/01/2011 Option Purchased 2,300 45.0000 AMER 16/01/2010 Option Purchased 100 22.5000 AMER 22/01/2011 Option Purchased 1,800 30.0000 AMER 22/08/2009 Option Purchased 1,200 40.0000 AMER 21/11/2009 Option Purchased 1,100 30.0000 AMER 21/11/2009 Option Purchased 1,000 55.0000 AMER 22/01/2011 Option Purchased 900 25.0000 AMER 22/01/2011 Option Purchased 700 35.0000 AMER 16/01/2010 Option Purchased 600 22.5000 AMER 22/08/2009 Option Purchased 400 50.0000 AMER 21/11/2009 Option Purchased 300 35.0000 AMER 21/11/2009 Option Purchased 87,900 35.0000 AMER 22/08/2009 Option Purchased 2,500 35.0000 AMER 18/07/2009 Notes 1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell should also be given on this form. 2. For all prices and other monetary amounts, the currency must be stated. For details of the Code's dealing disclosure requirements, see Rule 8 and its Notes which can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

Companies

Barclays (BARC)
UK 100

Latest directors dealings